News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Single-cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug-resistance in lung adenocarcinoma
- Identification and Functional Validation of PTH2R as a Therapeutic Target in Lung Adenocarcinoma
- Melatonin inhibits fibroblast cell functions and hypertrophic scar formation by enhancing autophagy through the MT2 receptor-inhibited PI3K/Akt /mTOR signaling
- Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin
- Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors
- Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination
- Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway
- Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
- Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
- A Review of Biological and Pharmacological Actions of Melatonin: Oxidant and Prooxidant Properties
- Melatonin as Antioxidant Under Pathological Processes
- Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage
- Melatonin as antioxidant, geroprotector and anticarcinogen
- The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor
- Does the use of melatonin overcome drug resistance in cancer chemotherapy?
- Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
- Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
- Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer